Stifel Financial
ANIP icon

Stifel Financial’s ANI Pharmaceuticals ANIP Stock Holding History

Stifel Financial’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$867K Sell
10,468
-303
-3% -$24.3K ﹤0.01% 2646
2026
Q1 		$828K Buy
10,771
+48
+0.4% +$3.75K ﹤0.01% 2563
2025
Q4 		$846K Buy
10,723
+1,762
+20% +$153K ﹤0.01% 2548
2025
Q3 		$821K Sell
8,961
-177
-2% -$14.4K ﹤0.01% 2517
2025
Q2 		$596K Sell
9,138
-145
-2% -$9.44K ﹤0.01% 2667
2025
Q1 		$622K Buy
9,283
+859
+10% +$51.3K ﹤0.01% 2543
2024
Q4 		$466K Buy
8,424
+1,425
+20% +$81.8K ﹤0.01% 2718
2024
Q3 		$418K Buy
+6,999
New +$427K ﹤0.01% 2783
2020
Q1 		– Sell
-3,245
Closed -$201K – 2820
2019
Q4 		$201K Buy
3,245
+450
+16% +$29.8K ﹤0.01% 2770
2019
Q3 		$203K Sell
2,795
-126
-4% -$9.43K ﹤0.01% 2650
2019
Q2 		$242K Sell
2,921
-114
-4% -$8.11K ﹤0.01% 2614
2019
Q1 		$214K Buy
+3,035
New +$179K ﹤0.01% 2553
2018
Q4 		– Sell
-3,847
Closed -$217K – 2664
2018
Q3 		$217K Buy
3,847
+17
+0.4% +$1.04K ﹤0.01% 2540
2018
Q2 		$256K Buy
3,830
+164
+4% +$10.2K ﹤0.01% 2395
2018
Q1 		$215K Buy
+3,666
New +$233K ﹤0.01% 2436
2017
Q4 		– Sell
-6,703
Closed -$349K – 2650
2017
Q3 		$349K Buy
+6,703
New +$320K ﹤0.01% 2087

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stifel Financial's ANIP Position: Q2 2026 in Review

Stifel Financial reduced its ANI Pharmaceuticals (ANIP) stake by 2.8% in Q2 2026, selling an estimated $24.3K and leaving 10,468 shares worth $867K. The position accounts for ﹤0.01% of the portfolio, ranked #2646.

Stifel Financial first reported a position in ANIP in Q3 2017 and has held it in 16 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Stifel Financial held 10,468 shares of ANI Pharmaceuticals worth $867K as of Q2 2026.
  • Stifel Financial sold 303 ANI Pharmaceuticals shares in Q2 2026, an estimated $24.3K.
  • ANI Pharmaceuticals made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2646 holding.
  • Stifel Financial first reported a position in ANI Pharmaceuticals in Q3 2017 and has held it in 16 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.